Suzhou MedicalSystem Technology Co., Ltd. (SHA:603990)
China · Delayed Price · Currency is CNY 14.92
+0.01 (0.07%)
Feb 27, 2026, 3:00 PM CST
SHA:603990 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 324 | 461.39 | 616.95 | 304.25 | 352.11 | 306.31 |
Other Revenue | 2.68 | 2.68 | 1.19 | 1.25 | 1.74 | 1.77 |
| 326.68 | 464.07 | 618.14 | 305.51 | 353.85 | 308.08 | |
Revenue Growth (YoY) | -48.01% | -24.93% | 102.33% | -13.66% | 14.86% | -7.52% |
Cost of Revenue | 180.37 | 412.9 | 505.32 | 90.05 | 106.86 | 85.37 |
Gross Profit | 146.31 | 51.17 | 112.82 | 215.46 | 246.99 | 222.71 |
Selling, General & Admin | 162.73 | 227.7 | 271.5 | 122.93 | 147.19 | 129.68 |
Research & Development | 29.66 | 51.18 | 50.04 | 47.41 | 48 | 43.03 |
Other Operating Expenses | 77.9 | -6.2 | -6.19 | -9.57 | -12.79 | -15.73 |
Operating Expenses | 277.58 | 279.48 | 331.73 | 182.16 | 203.16 | 174.67 |
Operating Income | -131.27 | -228.3 | -218.91 | 33.3 | 43.83 | 48.04 |
Interest Expense | -26.35 | -71.81 | -48.3 | -3.97 | -6.69 | -6.6 |
Interest & Investment Income | 27.24 | 3.7 | 11.92 | 10.09 | 8.76 | 1.22 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.11 | - | -0 | -0.76 |
Other Non Operating Income (Expenses) | -18.58 | -18.64 | -0.42 | 0.29 | 0.74 | -2.16 |
EBT Excluding Unusual Items | -148.98 | -315.07 | -255.6 | 39.71 | 46.64 | 39.74 |
Gain (Loss) on Sale of Investments | -1.66 | -0.44 | -2.32 | 0.07 | 1.14 | -2.86 |
Gain (Loss) on Sale of Assets | -0.01 | -0.21 | -0.03 | -0.06 | 0.09 | -0.01 |
Asset Writedown | 1.04 | -31.44 | -0.02 | -0 | -0.05 | -0.08 |
Other Unusual Items | 93.42 | 93.42 | -4.01 | 3.84 | 3.51 | 11.78 |
Pretax Income | -56.19 | -253.73 | -261.99 | 43.56 | 51.34 | 48.57 |
Income Tax Expense | 19.06 | 23.87 | 3.25 | 8.07 | 7.83 | 6.61 |
Earnings From Continuing Operations | -75.25 | -277.6 | -265.24 | 35.49 | 43.5 | 41.97 |
Minority Interest in Earnings | -2.73 | -1.88 | -4.18 | -1.93 | -1.55 | -6.52 |
Net Income | -77.98 | -279.47 | -269.42 | 33.56 | 41.95 | 35.44 |
Net Income to Common | -77.98 | -279.47 | -269.42 | 33.56 | 41.95 | 35.44 |
Net Income Growth | - | - | - | -20.00% | 18.37% | -24.41% |
Shares Outstanding (Basic) | 309 | 304 | 306 | 280 | 273 | 250 |
Shares Outstanding (Diluted) | 309 | 304 | 306 | 280 | 273 | 250 |
Shares Change (YoY) | 1.77% | -0.78% | 9.47% | 2.53% | 9.29% | 0.77% |
EPS (Basic) | -0.25 | -0.92 | -0.88 | 0.12 | 0.15 | 0.14 |
EPS (Diluted) | -0.25 | -0.92 | -0.88 | 0.12 | 0.15 | 0.14 |
EPS Growth | - | - | - | -21.98% | 8.31% | -24.99% |
Free Cash Flow | -51.38 | -263.69 | -916.49 | 25.93 | -4.95 | 91.6 |
Free Cash Flow Per Share | -0.17 | -0.87 | -2.99 | 0.09 | -0.02 | 0.37 |
Dividend Per Share | - | - | - | - | - | 0.039 |
Dividend Growth | - | - | - | - | - | -32.35% |
Gross Margin | 44.79% | 11.03% | 18.25% | 70.52% | 69.80% | 72.29% |
Operating Margin | -40.18% | -49.20% | -35.41% | 10.90% | 12.39% | 15.59% |
Profit Margin | -23.87% | -60.22% | -43.59% | 10.98% | 11.86% | 11.50% |
Free Cash Flow Margin | -15.73% | -56.82% | -148.27% | 8.49% | -1.40% | 29.73% |
EBITDA | -51.93 | -171.75 | -192.76 | 47.41 | 57.36 | 62.67 |
EBITDA Margin | -15.90% | -37.01% | -31.18% | 15.52% | 16.21% | 20.34% |
D&A For EBITDA | 79.35 | 56.55 | 26.16 | 14.12 | 13.53 | 14.63 |
EBIT | -131.27 | -228.3 | -218.91 | 33.3 | 43.83 | 48.04 |
EBIT Margin | -40.18% | -49.20% | -35.41% | 10.90% | 12.39% | 15.59% |
Effective Tax Rate | - | - | - | 18.52% | 15.25% | 13.60% |
Revenue as Reported | 326.68 | 464.07 | 618.14 | 305.51 | 353.85 | 308.08 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.